HealioScan | AI-Driven Multimodal Cancer Diagnostics for Early Detection

HealioScan is a precision healthtech company developing the PAMLEE™ Model—an explainable, HIPAA-compliant AI system for early cancer detection across imaging, clinical, and genomic data.

Rooted in real-world oncology challenges and inspired by personal loss, our mission is to make deadly cancers like pancreatic, lung, and breast cancer more detectable at earlier, more treatable stages. PAMLEE (Pan-cancer AI Multimodal Learning and Explainability Engine) supports multiple cancer types using shared model components, fine-tuned for each disease.

The PAMLEE platform:

* Uses multimodal AI (imaging, clinical text, genomics) for accurate diagnostics
* Employs explainable AI techniques (SHAP, Grad-CAM, TCAV, BioBERT attention)
* Generates synthetic data to address underrepresented subtypes
* Offers non-engineer workflows so clinicians can manage and update models with ease
* Integrates seamlessly into the HealioScan.com HIPAA- and FDA-aligned web platform
* Supports regulatory readiness for Software as a Medical Device (SaMD)

HealioScan isn’t just innovating—we’re operationalizing deep tech into clinical workflows that are intuitive, explainable, and lifesaving. By making cancer visible earlier and actionable faster, we empower physicians and bring new hope to patients.

HealioScan – Healing begins with intelligent insight.

---

Healioscan

Org chart

Teams

Offices

Healioscan

Org chart

Teams

Offices

Related companies